Corcept Therapeutics
The Director, Market Access is responsible for defining and executing the market access, pricing, and reimbursement strategy for Corcept’s oncology portfolio in Germany. This role is critical to ensuring timely, sustainable, and compliant patient access through successful navigation of Germany’s complex access environment.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
1998
Corcept Therapeutics is a biopharmaceutical company that discovers and develops medicines that modulate the glucocorticoid receptor to treat disorders driven by excess cortisol. The company commercialized Korlym (mifepristone) for hyperglycemia secondary to endogenous Cushing’s syndrome and is advancing next‑generation, selective GR modulators (for example, relacorilant) through clinical development. Corcept combines translational science, clinical trials, and commercial capabilities to target endocrine and oncology indications where cortisol signaling contributes to disease. The company is headquartered in Menlo Park, California.
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT
8 hours ago
REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026
1 day ago
Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements
7 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Corcept Therapeutics.
3% above the average for this role
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm – Company Announcement - FT.com
12 hours ago
Director Market Access - Innovative products (m/f/d)
Viatris
Associate Director, Market Access, Germany
Revolution Medicines
Director, Market Access Strategy, Cardiovascular & Metabolic
Novartis
Director, Specialty Care Global Pricing and Market Access
GSK plc
Market Access Specialist
Servier
Director, Value Market Access Strategy & Marketing
Iovance Biotherapeutics